Mr. Dron is a highly experienced healthcare executive with a decade of multidisciplinary experience spanning clinical work, health technology, and leadership roles in both corporate and research settings. His expertise ranges from hands-on clinical diagnostics to leading high-level research teams and advancing real-world evidence applications in healthcare. Starting his career in clinical science, Louis honed his expertise in medical diagnostics, quality assurance, and hospital systems while working in top-tier hospitals in the UK. Over the years, Louis transitioned from clinical settings to high-impact director roles in research and development, where he led teams on projects that integrated real-world evidence, biostatistics, and epidemiology into healthcare decision-making. Louis also acts as an advisor to the Canadian Drug Agency and the Bill & Melinda Gates Foundation. He is a graduate of the University of Manchester and the University of Leicester.

Dr. Thorlund, with over 15 years of experience in data science and AI, is an established serial entrepreneur having been involved in the foundation of five Canadian-based businesses (with two successful multi-million dollar exits) over the past decade focused on health technologies. Kristian is an expert in AI and data analysis, ranking within the top 1% of researchers in his field worldwide by citation count. Alongside his business interests, Kristian is a part-time professor at McMaster University, acquiring over $6m in grants. He is a graduate of the University of Copenhagen and McMaster University.

Mr. Stadnyk is a distinguished public company executive with over fifteen years of experience leading multi-million-dollar initiatives across healthcare, wellness, technology, cannabis, and private equity sectors. As a C-suite executive, Mr. Stadnyk has excelled in navigating complex financial landscapes, exemplified by his strategic role as Head of Corporate Finance at The Supreme Cannabis Company (TSX:FIRE), leading to its $435 million acquisition by Canopy Growth Corporation. He founded DC Acquisition Corp. – a capital pool company on the TSX Venture Exchange (“TSX”), raising $3 million in seed and IPO capital and acquiring Kiaro Brands, boosting its annual sales to a peak of $25 million. Most recently, Mr. Stadnyk served as the Head of Life Sciences at the TSX and TSXV also covering innovation (technology and clean tech) overseeing more than 140 listed issuers, facilitating their public transitions and promoting growth in a sector with over $26 billion in overall market capitalization.

Dr. Sammis is a worldwide leader in chemistry, acting as an accomplished academic with nearly two decades of experience. Currently, a professor at the University of British Columbia, he has built an exceptional teaching record, excelling across a wide range of courses, student evaluations, course development, creation of innovative materials, and teaching leadership. At his time at UBC, Dr. Sammis has acquired over $5.5m in grants. Outside of his research group being at the forefront of pioneering advances in radical and photochemical processes, Glenn has acted as an advisor for synthesis problems for over 10 private companies. He is a graduate of Stanford University and Harvard University.

Dr. Harari is a highly experienced statistician and data scientist with over 15 years of experience across various industries, including healthcare, pharmaceuticals, finance and academia. He has a proven track record in both practical data analysis and methodological research, consistently mentoring teams and advancing innovative solutions in healthcare, AI, and statistical science. In recent years, in addition to his tenure at Redwood AI, he served as a Head of Biostatistics at Purpose Life Science, and has previously worked for PayPal. He is a graduate of Ben Gurion University and Tel Aviv University.

Dr. Lat is a passionate researcher and data scientist with a decade of experience. His research spans multiple disciplines, including bioinformatics, biophysics, biochemistry, molecular biology, and DNA nanotechnology. He has also worked in biostatistics and data science, applying these tools to extract insights from complex datasets. He is a graduate of IIT Kanpur and Simon Fraser University.